Peptide profile

Sermorelin

Also known as GHRH(1-29)NH2

Growth hormone-releasing hormone receptor agonist

Clinical research
Editorial laboratory imageryScience, with its context intact.
What to know

The evidence
in perspective.

The cited study examined children with growth hormone deficiency. Historical pediatric evidence does not establish adult longevity benefits or the approval of a current compounded product.

View the supporting source
Research area
Endocrine
Biological target or mechanism
Growth hormone-releasing hormone receptor agonist
Evidence context
Clinical research
Availability
Availability requires pharmacy review
From information to a conversation

Clinical decisions stay
with clinical professionals.

This profile is a research reference. Your prescriber and pharmacy assess the relevant clinical and dispensing pathway. Inclusion here is not an offer to sell this compound.

Start a conversation

Find your lane.

Tell us about your business and what you want to explore.

Review your details before sending. Please do not include patient information.